• 1
    Hsing AW,Rashid A,Devesa SS,Fraumeni JF,Jr. Biliary tract cancer. In: SchottenfeldD,FraumeniJF,Jr, eds. Cancer epidemiology and prevention. Oxford: Oxford University Press, 2006. 787800.
  • 2
    Lazcano-Ponce EC,Miquel JF,Munoz N,Herrero R,Ferrecio C,Wistuba II,Alonso de Ruiz P,Aristi Urista G,Nervi F. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin 2001; 51: 34964.
  • 3
    Hsing AW,Gao Y-T,Devesa SS,Jin FFraumeni JF,Jr. Rising incidence of biliary tract cancer in Shanghai, China, 1972–1992. Int J Cancer 1998; 73: 36870.
  • 4
    Strom BL,Soloway RD,Rios-Dalenz JL,Rodriguez-Martinez HA,West SL,Kinman JL,Polansky M,Berlin JA. Risk factors for gallbladder cancer. An international collaborative case-control study. Cancer 1995; 76: 174756.
  • 5
    De Groen PC,Geores GJ,LaRusso NF,Gunderson LL,Nagorney DM. Biliary tract cancers. N Engl J Med 1999; 341: 136878.
  • 6
    Ghadirian P,Simard A,Baillargeon J. A population-based case-control study of cancer of the bile ducts and gallbladder in Quebec, Canada. Rev Epidemiol Sante Publique 1993; 41: 10712.
  • 7
    Khan ZR,Neugut AI,Ahsan H,Chabot JA. Risk factors for biliary tract cancers. Am J Gastroenterol 1999; 94: 14952.
    Direct Link:
  • 8
    Chapman RW. Risk factors for biliary tract carcinogenesis. Ann Oncol 1999; 10: S308S311.
  • 9
    Nath G,Singh H,Shukla VK. Chronic typhoid carriage and carcinoma of the gallbladder. Eur J Cancer Prev 1997; 6: 5579.
  • 10
    Haswell-Elkins MR,Mairiang E,Mairiang P,Chaiyakum J,Chamadol N,Loapaiboon V,Sithithaworn P,Elkins DB. Cross-sectional study of Opisthorchis viverrini infection and cholangiocarcinoma in communities within a high-risk area in northeast Thailand. Int J Cancer 1994; 59: 5059.
  • 11
    Kuper H,Ye W,Broome U,Romelsjo A,Mucci LA,Ekbom A,Adami HO,Trichopoulos D,Nyren O. The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis. Hepatology 2001; 34: 71418.
  • 12
    Dutta U,Garg PK,Kumar R,Tandon RK. Typhoid carriers among patients with gallstones are at increased risk for carcinoma of the gallbladder. Am J Gastroenterol 2000; 95: 7847.
    Direct Link:
  • 13
    Shukla VK,Singh H,Pandey M,Upadhyay SK,Nath G. Carcinoma of the gallbladder–is it a sequel of typhoid? Dig Dis Sci 2000; 45: 9003.
  • 14
    Chen R,Zou S,Zhao X. The expression of hepatitis C virus in hilar cholangiocarcinoma and implication. Chin J Exp Surg 2000; 17: 2235.
  • 15
    Yin F,Chen B. Detection of hepatitis C virus RNA sequences in hepatic portal cholangiocarcinoma tissue by reverse transcription polymerase chain reaction. Chin Med J 1998; 111: 106870.
  • 16
    Wang WL,Gu GY,Hu M. Expression and significance of HBV genes and their antigens in human primary intrahepatic cholangiocarcinoma. World J Gastroenterol 1998; 4: 3926.
  • 17
    Liu E,Sakoda LC,Gao Y-T,Rashid A,Shen MC,Wang BS,Deng J,Han TQ,Zhang BE,Fraumeni JF,Jr,Hsing AW. Aspirin use and risk of biliary tract cancer: a population-based study in Shanghai, China. Cancer Epidemiol Biomarkers Prev 2005; 14: 131518.
  • 18
    Ueki T,Hsing AW,Gao YT,Wang BS,Shen MC,Cheng J,Deng J,Fraumeni JF,Jr,Rashid A. Alterations of p16 and prognosis in biliary tract cancers from a population-based study in China. Clin Cancer Res 2004; 10: 171725.
  • 19
    Wang BS,Qin J,Deng J,Zhang BH,Han TQ,Shen MC,Rashid A,Hsing AW,Gao YT. A survey on the diagnosis and treatment of biliary tract cancers in Shanghai. Zhonghua Wai Ke Za Zhi 2005; 43: 4559.
  • 20
    Hou L,Xu J,Gao YT,Rashid A,Zhang L,Sakoda LC,Sheng MC,Wang BS,Deng J,Han TQ,Zhang BE,Meyers D et al. CYP17 MspA1 polymorphism and the risk of biliary tract cancer and stones: a population-based study in Shanghai, China. Int J Cancer 2005; 118: 284753.
  • 21
    Zhang X,Andreotti G,Gao YT,Deng J,Liu EJ,Rashid A,Wu K,Sun L,Sakoda L,Cheng J,Sheng MC,Wang BS et al. Tea consumption and risk of biliary tract cancers and stones: a population-based case-control study in Shanghai, China. Int J Cancer 2006; 118: 308994.
  • 22
    Sakoda LC,Gao YT,Rashid A,Chen BE,Chen J,Rosenberg P,Deng J,Shen MC,Wang BS,Han TQ,Zhang BE,Webb HC et al. Prostaglandin synthase 2 gene polymorphisms and risk of biliary tract cancer: a population-based study in Shanghai, China. Carcinogenesis 2006; 27: 12516.
  • 23
    Breslow NE,Day NE. Statistical methods in cancer research, vol. 1:The analysis of case-control studies. Lyon, France: IARC, 1980.
  • 24
    Acalovschi M,Dumitrascu DL,Nicoara CD. Gallbladder contractility in liver cirrhosis: comparative study in patients with and without gallbladder stones. Dig Dis Sci 2004; 49: 1724.
  • 25
    Acalovschi M,Blendea D,Feier C,Letia AI,Ratiu N,Dumitrascu DL,Veres A. Risk factors for symptomatic gallstones in patients with liver cirrhosis: a case-control study. Am J Gastroenterol 2003; 98: 185660.
  • 26
    Conte D,Fraquelli M,Fornari F,Lodi L,Bodini P,Buscarini L. Close relation between cirrhosis and gallstones: cross-sectional and longitudinal survey. Arch Intern Med 1999; 159: 4952.
  • 27
    Maggi A,Solenghi D,Panzeri A,Borroni G,Cazzaniga M,Sangiovanni A,De Fazio C,Salerno F. Prevalence and incidence of cholelithiasis in patients with liver cirrhosis. Ital J Gastroenterol Hepatol 1997; 29: 3305.
  • 28
    Del Olmo JA,Garcia F,Serra MA,Maldonado L,Rodrigo JM. Prevalence and incidence of gallstones in liver cirrhosis. Scand J Gastroenterol 1997; 32: 10615.
  • 29
    Buchner AM,Sonnenberg A. Factors influencing the prevalence of gallstones in liver disease: the beneficial and harmful influences of alcohol. Am J Gastroenterol 2002; 97: 9059.
    Direct Link:
  • 30
    Grassi M,Allevato C,Mammucari S,Lazzari S,Nocchi S. The prevalence of gallstones in patients suffering from liver cirrhosis: a clinico-statistical study of 350 patients. Ital J Gastroenterol 1992; 24: 3426.
  • 31
    Li CP,Hwang SJ,Lee FY,Chang FY,Lin HC,Lu RH,Chu CJ,Lee SD. Evaluation of gallbladder motility in patients with liver cirrhosis: relationship to gallstone formation. Dig Dis Sci 2000; 45: 110914.
  • 32
    Yuan JM,Govindarajan S,Henderson BE,Yu MC. Low prevalence of hepatitis C infection in hepatocellular carcinoma (HCC) cases and population controls in Guangxi, a hyperendemic region for HCC in the People's Republic of China. Br J Cancer 1996; 74: 4913.
  • 33
    Zhao S,Xu Z,Lu Y. A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in China. Int J Epidemiol 2000; 29: 74452.
  • 34
    Yu MC,Yuan JM,Govindarajan S,Ross RK. Epidemiology of hepatocellular carcinoma. Can J Gastroenterol 2000; 14: 7039.
  • 35
    Bosch FX,Ribes J,Borras J. Epidemiology of primary liver cancer. Semin Liver Dis 1999; 19: 2715.
  • 36
    Sceuer PJ. Viral hepatitis. In: MacSweenRNM,AnthonyPP,ScheuerPJ,BurtAD,PortmannBC, eds. Pathology of the liver,3rd edn. Hong Kong: Churchill Livingstone, 1994. 24368.
  • 37
    Yu SZ,Zi XL,Chen G. The relationship between viral hepatitis and primary liver cancer in four areas of China. Zhonghau Liu Xing Bing Xue Zazhi 1997; 18: 21416.
  • 38
    Acalovschi M. Cholangiocarcinoma: risk factors, diagnosis and management. Rom J Intern Med 2004; 42: 4158.
  • 39
    Jung YS,Lee KJ,Kim H,Kim WH,Kim IG,Yoo BM,Kim JH,Kim MW. Risk factor for extrahepatic bile duct cancer in patients with anomalous pancreaticobiliary ductal union. Hepatogastroenterology 2004; 51: 9469.
  • 40
    Burak K,Angulo P,Pasha TM,Egan K,Petz J,Lindor KD. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol 2004; 99: 5236.
    Direct Link:
  • 41
    Jin F,Devesa SS,Chow WH,Zheng W,Ji BT,Fraumeni JF,Jr,Gao YT. Cancer incidence trends in urban Shanghai, 1972–1994: an update. Int J Cancer 1999; 83: 43540.
  • 42
    Alter MJ,Kruszon-Moran D,Nainan OV,McQuillan GM,Gao F,Moyer LA,Kaslow RA,Margolis HS. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341: 55662.
  • 43
    Merican I,Guan R,Amarapuka D,Alexander MJ,Chutaputti A,Chien RN,Hasnian SS,Leung N,Lesmana L,Phiet PH,Sjalfoellah Noer HM,Sollano J et al. Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol 2000; 15: 135661.
  • 44
    Maddrey WC. Hepatitis B- an important public health issue. Clin Lab 2001; 47: 515.
  • 45
    Ito S,Yao DF,Nii C,Hibino S,Kamamura M,Nisikado T,Honda H,Shimizu I,Meng XY. Epidemiological characteristics of the incidence of hepatitis C virus (C100-3) antibodies in patients with liver diseases in the inshore area of the Yangtze River. J Gastroenterol Hepatol 1993; 8: 2327.
  • 46
    Donato F,Boffetta P,Puoti M. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 1998; 75: 34754.
  • 47
    McQuillan GM,Coleman PJ,Kruszon-Moran D,Moyer LA,Lambert SB,Margolis HS. Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994. Am J Public Health 1999; 89: 1418.